The GPcog for detecting a population with a high risk of dementia;Intérêt du GPcog pour le repérage d'une population âgée à risque élevé de démence

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 4, Issue 1, 2006, Pages 69-77

  Thomas, Philippe ^a   Hazif Thomas, Cyril ^b   Viéban, François ^a   Faugeron, Philippe ^a   Peix, Richard ^a   Clément, Jean Pierre ^a  

^a CENTRE HOSPITALIER ESQUIROL   (France)

^b UF Psychiatrie du Sujet Âgé   (France)

Author keywords

Dementia; Detection; GPcog; Screening test

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; FEMALE; HUMAN; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; RATING SCALE; RISK FACTOR; SHORT TERM MEMORY;

AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PSYCHOMETRICS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 33645226458     PISSN: 17601703     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kulas JF, Naugle RI. Indications for neuropsychological assessment. Cleve Clin J Med 2003; 70: 785-92.
2. Brodaty H. GPaCOG: screening test for dementia for use in primary care. Int Psychogeriatr 2003; 15 (Suppl. 2): S250.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition DSM-IV. Washington: American Psychiatric Press, 1994.
4. McKhann G, Drachmen D, Folstein M, Katzman R, Price D, Stadlan EM. Report of the NINCDS/ADRDA work group under the hospice of department of health and human service task force on Alzheimer's disease. Neurology 1984; 34: 939-44.
5. Folstein MF, Folstein SE, McHugh PR. Mini-mental state, A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
6. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. Les 5 mots: un test simple et sensible pour le diagnostic de la maladie d'Alzheimer. Presse Med 2002; 31: 1696-9.
7. Vetel J. Agir: où, quand, comment, pourquoi? Revue de Gériatrie 1994; 9: 647-65.
8. Thomas P, Hazif-Thomas C, Billon R, Faugeron P, Peix R, Brodaty R. Un nouvel instrument de repérage de la démence chez la personne âgée: le GPcog. Revue Francophone de Gériatrie et Gérontologie 2004; 11: 87-9.
9. Dartigues JF, Gagnon M, Michel P, Letennew L, Commenges D, Barberger-Gateau P, et al. Le programme de recherche Paquid sur l'épidémiologie de la démence. Méthodes et résultats initiaux. Rev Neurol (Paris) 1991; 147: 225-30.
10. Valcour VG, Masaki KH, Curb JD, Blanchette PL. The detection of dementia in the primary care setting. Arch Intern Med 2000; 160: 2964-8.
11. Alexopoulos GS. The depression-executive dysfunction syndrome of late life: a specific target for D3 agonists? Am J Geriatr Psychiatry 2001; 9: 22-9.
12. Alexoupoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993; 150: 1693-9.
13. Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int J Geriatr Psychiatry 2001; 16: 718-27.
14. Morris JC, Storandt M, Miller JP, Mckeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397-405.
15. Salomez JL. Actes du colloque éthique "Autour du diagnostic de maladie d'Alzheimer". Paris: Vuibert, 2004.
16. Schenk F, Leuba G, Bula C, Schenk F, Leuba G, Bula C. Neurosciences et cognition. Bruxelles: De Boeck, 2004.
17. Brodaty H, Moore CM. The clock drawing test for dementia of the Alzheimer's type: a comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry 1997; 12: 619-27.
18. Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002; 47: 723-33.
19. Scanlan J, Borson S. The mini-cog: receiver operating characteristics with expert and naive raters. Int J Geriatr Psychiatry 2001; 16: 216-22.
20. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000; 15: 1021-7.
21. Salomon PR, Hirschoff A, Kelly B, Relin M, Brush M, Deveaux RD, et al. A 7 minutes neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 1998; 55: 349-55.
22. Lipton RB, Katz MJ, Kuslansky G, Sliwinski MJ, Stewart WF, Verghese J, et al. Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc 2003; 51: 1382-90.
23. Kawas C, Karagiozis H, Resau L, Corrada M, Brookmeyer R. Reliability of the blessed telephone information-memory-concentration test. J Geriatr Psychiatry Neurol 1995; 8: 238-42.
24. Buschke H. Memory impairment screen. Int Psychogeriatr 2003; 15 (Suppl. 2): PB-022.
25. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, et al. Screening for dementia with the memory impairment screen. Neurology 1999; 5: 231-8.
26. Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Mobius HG, et al. Measuring cognition in advanced Alzheimer's disease for clinical trials. J Neural Transm Suppl 2002; 62: 135-48.
27. Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clarn CM, et al. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11 (Suppl. 2): S51-S56.
28. Brodaty H, Conneally M, GauthierS, Jennings C, Lennox A, Lovestone S. Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc Disord 1995; 9: 182-7.